Reach Us +44-1202068036
Tissue Homing Of Inflammatory Neutrophils During Sepsis Is Mediated By Integrin VLA-3 (CD49c/CD29) | 13489
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Tissue homing of inflammatory neutrophils during sepsis is mediated by integrin VLA-3 (CD49c/CD29)

International Conference on Hematology & Blood Disorders

Pranita P. Sarangi

ScientificTracks Abstracts: J Blood Disord Transfus

DOI: 10.4172/2155-9864.S1.002

During sepsis there is aberrant activation, migration and sequestration of neutrophils in visceral organsthat leads to widespread release of pro-inflammatory mediators contributing to multi-organ failure and death. Interaction of cell surface integrins with their counterpart ligands, results in the adherence of circulating neutrophils and directed migration to infection sites.In our study, we show that administration of a cyclic analog of RGD peptide (Arg-Gly-Asp) significantly reduced the number of tissue-invading neutrophils and the degree of sepsis-induced lethality in mice as compared to control peptide. Secondly, β 1 integrin (CD29) and more specifically VLA-3(CD49c/CD29) is dramatically up regulated on a subpopulation of neutrophils isolated from both human septic patients and mouse sepsis models. Compared with the Gr 1high CD11b high VLA- 3low granulocyte population, Gr 1high CD11b high VLA-3 high cells from septic animals displayed hyper-inflammatory phenotypes.Administration of VLA-3 antagonist peptides and conditional genetic ablation of VLA(3)/integrin from granulocytes also improved survival and bacterial clearance in septic animals. Thus, our results indicate that expression of VLA(3)/integrin is important for modulating neutrophil trafficking during sepsis, and therapeutics specifically targeted against VLA(3)/integrin may be beneficial.
Pranita P. Sarangi is a research fellow at the National Institutes of Health. She is a graduate of the University of Tennessee, with postdoctoral training at Center for Vaccine Biology and Immunology, University of Rochester Medical Center. She has published 8 first author and 6 co-author papers in reputed peer reviewed journals including a book chapter.